Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass C1 - Strictly Controlled - PE Medical

ESC Medication Library · Revision 4

← Medication library · Compare sanctioning bodies

Clenbuterol,
Ventipulmen syrup

Medication Facts

Performance enhancing
Yes
Total hours to clear
168
Frequently used
Most Prescribed
ESC ID
CLENBU-0222
Trade names
Ventipulmin
Drug type
Beta-2 adrenergic agonist

**stacking candidate**
Plasma half-life · hours
10-12 Hrs
Equine dosing
0.5 mL/100 LBS.
Cmax · peak plasma concentration
650 pg/mL
Tmax · time to peak plasma concentration
10 minutes
ESC concentration guidance
May not exceed (LDL) Lowest Detectable Level of .05 ng/mL or 50 picograms per mL
Primary withdrawal · hours
50
Washout withdrawal · hours
72
ESC control type
C1 - Strictly Controlled - Restricted - Performance
Medication report required
MED REPORT REQUIRED

Uses & side effects

Asthma Pulminary

Drug interactions

A single competition dose of Clenbuterol cannot exceed 0.5 mL/100 LBS. A 72 hour WD is required for any single dosing greater than 0.5 mL/100lbs, **Severely Contraindicated if used with Albuteral or Dexamethasone at which time 72 hour WD is required. **Severely Contraindicated if used with Albuteral or Dexamethasone at which time 72 hour WD is required.

SEVERE CONTRAINDICATION - when used with Albuteral. Increases effecacy significantly when used with Dexamethasone - often times Dex is used with Clenbuteral to overcome the resistancy developed by recurring use of Clenbuterol which is a prescription medication primarily used in veterinary medicine to treat horses suffering from airway obstructions, such as Recurrent Airway Obstruction (RAO)—commonly known as "heaves" or asthma. The clinical breakdown regarding its half-life, administration, and dosing schedule is detailed below.1. Half-Life in HorsesThe elimination half-life of clenbuterol in horses depends slightly on how it is given and whether it is a single dose or repeated use. Oral Administration: Following repeated oral doses, the plasma elimination half-life is typically between 7 and 13 hours (with some studies showing up to 21 hours for total elimination).Intravenous (IV) Administration: Following a single IV injection, the half-life is slightly shorter, averaging around 9 hours. Note on Equine Regulatory Testing: While the active therapeutic effects fade within hours, clenbuterol can remain detectable in a horse’s urine for up to 11 to 12 days after the final dose. Because it is highly regulated in competitive equine sports, strict withdrawal guidelines must be followed.2. Administration MethodClenbuterol is most commonly administered orally in the form of a clear, viscous liquid syrup (the most prominent brand name being Ventipulmin). Directly or via Feed: The syrup is administered twice daily, either drawn up into a syringe and given directly into the horse's mouth, or topically added directly onto the grain portion of their feed. Injectable Forms: Though much less common for daily maintenance, intravenous or parenteral (injectable) forms exist and are managed strictly by veterinarians for acute episodes.3. Standard Dosing ScheduleVeterinarians use a strict step-wise dosing schedule. Treatment always starts at the lowest effective baseline dose. If the horse does not show clinical improvement after 3 days, the dosage is incrementally increased up to a maximum ceiling. The standard starting dose is 0.8 micrograms per kilogram ($\mu\text{g/kg}$) of body weight, administered twice daily (every 12 hours). Ventipulmin Syrup Dosing Progression (based on a 0.0725 mg/mL concentration)Treatment StageDosage RateAmount Per 100 lbs of Body WeightDurationInitial Dose (Days 1–3)$0.8\text{ }\mu\text{g/kg}$0.5 mL3 days (6 treatments)Step 2 (If no improvement)$1.6\text{ }\mu\text{g/kg}$1.0 mL3 days (6 treatments)Step 3 (If no improvement)$2.4\text{ }\mu\text{g/kg}$1.5 mL3 days (6 treatments)Maximum Dose (If no improvement)$3.2\text{ }\mu\text{g/kg}$2.0 mLUp to 30 days totalNon-Responders: If the horse shows no respiratory improvement at the maximum dose ($3.2\text{ }\mu\text{g/kg}$) after 3 days, they are considered a non-responder, and the medication should be discontinued under veterinary guidance.Duration: Once an effective dose is established, treatment is typically maintained for 30 days. At that point, the drug is withdrawn to see if the airway obstruction symptoms recur. Potential Side EffectsWhen starting clenbuterol or raising the dose, horses frequently exhibit mild, transient side effects typical of beta-2 agonists. These include increased heart rate (tachycardia), muscle tremors, sweating (particularly around the neck), and mild restlessness. These side effects usually subside within a few days as the horse's system acclimates.Clenbuterol (often marketed as Ventipulmin) is a \(\beta _{2}\)-agonist used as a bronchodilator in horses. Its drug interactions are primarily centered on other medications that affect the cardiovascular or nervous systems, as clenbuterol can increase heart rate and cause excitability. Clenbuterol should not be used with Dexamethasone as this has performance enhancing effects, At 12 withdraw point concentration levels are <1 ng/mL

Contraindications

Clenbuteral, Albuterol, Salbutamol, Ventipulmen, Tri-Hist

Government Numbers

Ventipulmin clenbuterol HCl syrup, 72.5 mcg/mL: NADA 140-973. NDC 0010-3017-02 (100 mL) and 0010-3017-03 (330 mL). Labeler: Boehringer Ingelheim Animal Health USA Inc. Identifiers apply to this oral syrup. Reviewed September 18, 2026. Full label: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=691e6c6a-0ac6-4cc2-bd87-954bf6716735

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

VIO401.5, .6, .8

Reviewed 2026-09-23

No permitted competition dosing regimen.No permitted plasma threshold stated.No permitted-use withdrawal allowance established here.Explicitly prohibited.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

Other racing scopes must follow their specific ARCI model provisions. NOTE: "A" penalty for quarter horse races. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

CTMS 4.2.1; breed-specific footnotes; UCG 20.0 PDF p. 21

Reviewed 2026-09-23

No permitted regimen for Quarter Horse or Thoroughbred racing.Laboratory detection limit in plasma; no numeric allowed plasma value.No withdrawal allowance for prohibited breeds. Schedule retains 14-day guidance for harness only.Drug Class 3 · Penalty Class B. Prohibited in Quarter Horse and Thoroughbred racehorses.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.